Cargando…

Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19

Detalles Bibliográficos
Autores principales:	Vitali, Claudio, Minniti, Antonina, Caporali, Roberto, Del Papa, Nicoletta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Letter to the Editors-in-Chief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199727/ https://www.ncbi.nlm.nih.gov/pubmed/32416365 http://dx.doi.org/10.1016/j.thromres.2020.05.002

Ejemplares similares

Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome
por: Scudiero, Fernando, et al.
Publicado: (2021)

More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism
por: van Dam, L.F., et al.
Publicado: (2020)

Pulmonary embolism in a young pregnant woman with COVID-19
por: Martinelli, Ida, et al.
Publicado: (2020)

Three-month follow-up of pulmonary embolism in patients with COVID-19
por: Whyte, Martin B., et al.
Publicado: (2021)

Association between Covid-19 and Pulmonary Embolism (AC-19-PE study)
por: Miró, Òscar, et al.
Publicado: (2020)

Right ventricular dilation: The additive effect of mechanical ventilation on pulmonary embolism in Covid-19 patients
por: Tsolaki, Vasiliki, et al.
Publicado: (2020)

Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic
por: Husser, Daniela, et al.
Publicado: (2021)

Is pulmonary embolism occurring after SARS COV-2 vaccination provoked or unprovoked?
por: Catella, Judith, et al.
Publicado: (2022)

Systematic screening for pulmonary embolism using the YEARS algorithm in patients with suspected COVID-19 in the Emergency Department
por: Luu, Inge H.Y., et al.
Publicado: (2021)

Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study
Publicado: (2021)

Instruments for Outcome Evaluation of Specific Domains in Primary Sjögren’s Syndrome
por: Del Papa, Nicoletta, et al.
Publicado: (2021)

Validation of the YEARS algorithm and Wells' score with the age-adjusted cut-off to exclude pulmonary embolism in COVID-19 patients
por: Speksnijder, Esther M., et al.
Publicado: (2022)

Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study
por: Sindet-Pedersen, Caroline, et al.
Publicado: (2021)

Systemic thromboemboli in patients with Covid-19 may result from paradoxical embolization
por: Rajendram, Rajkumar, et al.
Publicado: (2020)

COVID-19 associated pulmonary thrombosis
por: van Nieuwkoop, C.
Publicado: (2020)

Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity
por: Minniti, Antonina, et al.
Publicado: (2020)

Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?
por: Del Papa, Nicoletta, et al.
Publicado: (2020)

Role of upfront CT pulmonary angiography at admission in COVID-19 patients
por: Jalaber, Carole, et al.
Publicado: (2020)

In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis
por: Mandal, Amit K.J., et al.
Publicado: (2021)

In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist
por: Wang, Lan, et al.
Publicado: (2020)

High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2020)

The Role of Interferons in the Pathogenesis of Sjögren’s Syndrome and Future Therapeutic Perspectives
por: Del Papa, Nicoletta, et al.
Publicado: (2021)

Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia
por: Beenen, L.F.M., et al.
Publicado: (2020)

Demystifying pulmonary vascular complications in severe coronavirus disease-19 pneumonia (COVID-19) in the light of clinico-radiologic-pathologic correlation
por: Parry, Arshed Hussain, et al.
Publicado: (2020)

Impact of COVID-19 outbreak in an Italian cohort of patients with systemic sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2020)

Management of Sjögren's Syndrome: Present Issues and Future Perspectives
por: Vitali, Claudio, et al.
Publicado: (2021)

Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination
por: Franchini, Massimo, et al.
Publicado: (2021)

Clinical course, management, and platelet activity assessment of splanchnic VITT: A case report
por: Corica, Bernadette, et al.
Publicado: (2021)

The effect of anticoagulation on clinical outcomes in novel Coronavirus (COVID-19) pneumonia in a U.S. cohort
por: Lynn, Lei, et al.
Publicado: (2021)

No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19
por: Porfidia, Angelo, et al.
Publicado: (2022)

The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
por: Previtali, Giulia, et al.
Publicado: (2020)

Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study
por: Rodríguez, Carmen, et al.
Publicado: (2021)

Gene Expression Profiles in Primary Sjögren's Syndrome With and Without Systemic Manifestations
por: Vitali, Claudio, et al.
Publicado: (2019)

Occurrence of Acute Pulmonary Embolism in COVID-19—A case series
por: Bavaro, Davide Fiore, et al.
Publicado: (2020)

Major cardiovascular events in patients with Coronavirus Disease 2019: Experience of a cardiovascular department of Northern Italy()
por: Bellosta, Raffaello, et al.
Publicado: (2021)

Therapeutic anticoagulation in COVID-19 patients
por: Belfaqeeh, O., et al.
Publicado: (2021)

When to use anticoagulation in COVID-19()()
por: Moll, Matthew, et al.
Publicado: (2021)

Therapeutic anticoagulation in COVID-19 patients
por: Lemos, Anna Cristina Bertoldi, et al.
Publicado: (2021)

Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?
por: Nielsen, Nathan D., et al.
Publicado: (2022)

The long haul COVID-19 arterial thrombosis
por: Borrelli, Maria Pia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cdprtnnh376qj3k6juebkve6l6